bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.06.14.496046

A spatial statistical framework for the parametric study of fiber networks: application to fibronectin deposition by normal and activated fibroblasts

Abstract

Changes in the spatial landscape of the extracellular matrix (ECM) in health and disease significantly impact the surrounding tissues. Quantifying the spatial variations in the fibrillar architecture of major ECM proteins could enable a profound understanding of the link between tissue structure and function. We propose a method to capture relevant ECM features using graph networks for fiber representation in normal and tumor-like states of 4 alternatively spliced isoforms of fibronectin (FN) associated with embryonic development and disease. Then, we construct graph-derived statistical parametric maps, to study the differences across variants in normal and tumor-like architectures. This novel statistical analysis approach, inspired from the analysis of functional magnetic resonance imaging (fMRI) images, provides an appropriate framework for measuring and detecting local variations of meaningful matrix parameters. We show that parametric maps representing fiber length and pore orientation isotropy can be studied within the proposed framework to differentiate among various tissue states. Such tools can potentially lead to a better understanding of dynamic matrix networks within the tumor microenvironment and contribute to the development of better imaging modalities for monitoring their remodeling and normalization following therapeutic intervention. Author SummaryDue to the complex architectural diversity of biological networks, there is an increasing need to complement statistical analyses with a qualitative and local description. The extracellular matrix (ECM) is one such network for which fiber arrangement has a major impact on tissue structure and function. Thus, a flexible numerical representation of fibrillar networks is needed for accurate analysis and meaningful statistical comparison of ECM in healthy and diseased tissue. First, we propose a versatile computational pipeline to study fiber-specific features of the ECM with graph networks. Then, we introduce a novel framework for the statistical analysis of graph-derived parametric maps, inspired from the statistical analysis of fMRI parametric maps. This analysis is useful for the quantitative/qualitative comparison of ECM fiber networks observed in normal and tumor-like, or fibrotic states. These methods are applied to study networks of fibronectin (FN), a provisional ECM component that dictates the organization of matrix structure. From 2D confocal images we analyzed architectural variations among 4 alternatively spliced isoforms of FN, termed oncofetal FN, that are prevalent in diseased tissue. We show how our approach can be used for the computation and statistical comparison of heterogeneous parametric maps representing FN variant-specific topological/geometrical features. These methods may be further developed and implemented into tumor tissue ECM profiling to decipher the specific roles of ECM landscapes and their remodeling in disease.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Grapa, A.-I., Efthymiou, G., Van Obberghen-Schilling, E., Blanc-Feraud, L., Descombes, X.. 2022-06-16. A spatial statistical framework for the parametric study of fiber networks: application to fibronectin deposition by normal and activated fibroblasts. https://doi.org/10.1101/2022.06.14.496046

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ex vivo human tumor slices more accurately predict patient responses to an oncolytic virus than in vivo mouse models

Immunotherapies, including oncolytic viruses (OV), are promising therapies that can enhance anti-tumor immune responses. However, preclinical success of immunotherapies in mouse models has not always translated to clinical benefit in cancer patients. This study compared preclinical efficacy and mechanism of action for ASP9801, a vaccinia virus expressing IL-7 and IL-12, using mouse models of colorectal cancer (CRC) in vivo and in human organotypic tumor slice models ex vivo. The murine surrogate for ASP9801 significantly reduced tumor volumes in treated and abscopal tumors in two different CRC models in vivo (MC38 and RO100). Treatment efficacy was accentuated when combined with anti-PD1 treatment, and single-cell RNA sequencing analysis revealed depletion of tumor cells and increased T cell infiltration and activation in both treated and abscopal tumors. However, human tissue analysis ex vivo (E-slices) using PDX models and patient samples showed that ASP9801 is not effective in CRC, consistent with clinical trial results. On the other hand, ASP9801 was highly effective in GBM, indicating indication-specific efficacy of ASP9801, and how E-slice assays can be used to identify treatment-sensitive indications. This study demonstrates the superiority of E-slices over mouse models for predicting clinical response and its utility in planning clinical trials.

cancer biology↗

Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I

Immunotherapy has transformed treatment for many cancers. In the aggressive and genetically heterogeneous diffuse large B-cell lymphoma (DLBCL), CD19 CAR T-cell therapy is highly effective, whereas immune checkpoint blockade has shown limited benefit. Loss of MHC expression is a common mechanism to escape T-cell cytotoxicity, and loss of MHC class I (MHC-I) and II are frequent in DLBCL. We applied imaging mass cytometry to diagnostic biopsies from younger, high-risk DLBCL patients to map the tumor microenvironment (TME) spatial architecture in relation to tumor cell MHC expression, mutational status, transcriptomic and proteomic profiles. Neighborhood analyses identified four TME subtypes: immune-cell depleted and three immune-infiltrated types (mixed, CD4 T cell-rich, CD8 T-cell/macrophage-rich). Depleted cases had shorter overall survival (p = 0.033) and increased expression of proteins involved in DNA replication and proliferation markers compared to infiltrated cases. Tumor cell MHC-I expression was heterogeneous. Cases with low frequency of MHC-I-pos tumor cells were enriched for the depleted TME type. MHC-I-pos tumor cells were surrounded by CD4 and CD8 T cells and M1 macrophages, whereas MHC-I-neg tumor cells were closer to other MHC-I-neg tumor cells. These findings suggest that TME-based classification incorporating tumor cell MHC-I status may improve individualized immunotherapy selection.

cancer biology↗

Cross-species analysis links cell-cell communication rewiring to NOTCH2 during serous endometrial carcinogenesis

Cell-cell interactions shape the fate of mutant cells during cancer initiation but how these interactions evolve during progression to pathologically recognizable lesions remain poorly understood. Here, we investigated cell-cell communication during serous endometrial carcinoma (SEC; also known as uterine serous carcinoma) development using a lineage-traceable mouse model and cross-species analyses of the mouse and human neoplastic endometrium. In mice, the early, pre-dysplastic stage was marked by a global decrease in inferred cell-cell interactions, followed by extensive communication network rewiring during neoplastic progression. Pathway-specific analysis revealed a similar pattern for NOTCH signaling, with NOTCH2 emerging as the dominant NOTCH receptor in Trp53/Rb1-mutant immature epithelial cells. Functionally, NOTCH2 promoted the outgrowth of more proliferative mutant organoids. Cross-species transcriptomic analysis identified conserved immature epithelial states in mouse and human neoplastic endometrial epithelium. In human tissues, NOTCH2 was overexpressed in serous endometrial intraepithelial carcinoma, a precursor of SEC, and in overt SEC. Furthermore, elevated NOTCH2 expression was associated with poor patient survival. These findings link cell-cell communication rewiring during experimental SEC development to conserved neoplastic epithelial states and identify NOTCH2 as an early marker and a potential target of disease interception.

cancer biology↗